779 related articles for article (PubMed ID: 19860235)
1. [Perioperative management of a patient with Parkinson's disease with intravenous infusion of levodopa].
Mizuno J; Kato S; Watada M; Morita S
Masui; 2009 Oct; 58(10):1286-9. PubMed ID: 19860235
[TBL] [Abstract][Full Text] [Related]
2. [High dose L-dopa infusion during general anesthesia for gastrectomy in a patient with parkinsonism].
Horai T; Nishiyama T; Yamamoto H; Hanaoka K
Masui; 2002 Jan; 51(1):42-5. PubMed ID: 11840662
[TBL] [Abstract][Full Text] [Related]
3. Perioperative medication withholding in patients with Parkinson's disease: a retrospective electronic health records review.
Fagerlund K; Anderson LC; Gurvich O
Am J Nurs; 2013 Jan; 113(1):26-35; quiz 36. PubMed ID: 23247677
[TBL] [Abstract][Full Text] [Related]
4. [A-56-year-old woman with parkinsonism, whose mother had Parkinson's disease].
Shimo Y; Takanashi M; Ohta S; Terashima K; Mori H; Shirai T; Miwa H; Mizuno Y
No To Shinkei; 2001 May; 53(5):495-505. PubMed ID: 11428377
[TBL] [Abstract][Full Text] [Related]
5. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
Koziorowski D; Friedman A
Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308
[TBL] [Abstract][Full Text] [Related]
6. [Perioperative management of the patient with atypical Parkinson disease].
Rundshagen I
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):49-52. PubMed ID: 8868535
[TBL] [Abstract][Full Text] [Related]
7. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
[TBL] [Abstract][Full Text] [Related]
8. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.
Antonini A; Isaias IU; Canesi M; Zibetti M; Mancini F; Manfredi L; Dal Fante M; Lopiano L; Pezzoli G
Mov Disord; 2007 Jun; 22(8):1145-9. PubMed ID: 17661426
[TBL] [Abstract][Full Text] [Related]
9. [Perioperative Management of a Patient with Severe Parkinson's Disease with Intravenous Levodopa Administration].
Terashima S; Yanagido Y; Watabe A; Yamane M; Morimoto Y
Masui; 2015 Aug; 64(8):845-8. PubMed ID: 26442421
[TBL] [Abstract][Full Text] [Related]
10. [Continuous treatment with levodopa of Parkinson disease].
Lundqvist C; Nystedt T; Reiertsen O; Grotli R; Beiske AG
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2638-40. PubMed ID: 16215609
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced Parkinson's disease with levodopa/carbidopa intestinal gel is associated with improvements in Hoehn and Yahr stage.
Munro Neville A; Parsons RW; Askmark H; Nyholm D
Parkinsonism Relat Disord; 2012 Jun; 18(5):686-7. PubMed ID: 22197121
[No Abstract] [Full Text] [Related]
12. [Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery].
Matsui H; Udaka F; Oda M; Kubori T; Nishinaka K; Kameyama M
No To Shinkei; 2004 Apr; 56(4):351-4. PubMed ID: 15237728
[TBL] [Abstract][Full Text] [Related]
13. [Intravenous infusion of L-dopa: current prospective therapies].
Peppe A; De Angelis D; Tolli VS; Rizzo PA; Scoppetta C
Riv Neurol; 1991; 61(5):197-200. PubMed ID: 1808680
[TBL] [Abstract][Full Text] [Related]
14. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson's disease.
Nyholm D
Expert Rev Neurother; 2006 Oct; 6(10):1403-11. PubMed ID: 17078781
[TBL] [Abstract][Full Text] [Related]
15. [Melanoma while using levodopa due to Parkinson's disease--causal association unlikely].
Wobbes T; Bonenkamp JJ
Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1286-8. PubMed ID: 12138675
[TBL] [Abstract][Full Text] [Related]
16. [Levodopa dependency in Parkinson's disease: case report and review].
Müller U; Reuter M; Hermann W; Gertz HJ
Nervenarzt; 2002 Sep; 73(9):887-91. PubMed ID: 12215883
[TBL] [Abstract][Full Text] [Related]
17. Cognitive improvement after duodenal levodopa infusion in cognitively impaired Parkinson's disease patients.
Sánchez-Castañeda C; Campdelacreu J; Miró J; Juncadella M; Jaumà S; Calopa M
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):250-1. PubMed ID: 19887096
[No Abstract] [Full Text] [Related]
18. Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
Stocchi F; Ruggieri S; Brughitta G; Agnoli A
J Neural Transm Suppl; 1986; 22():209-18. PubMed ID: 3465872
[TBL] [Abstract][Full Text] [Related]
19. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetic comparison of Sinemet and Grifoparkin (levodopa/carbidopa 250/25 mg) in Parkinson s disease: a single dose study].
Chaná P; Fierro A; Reyes-Parada M; Sáez-Briones P
Rev Med Chil; 2003 Jun; 131(6):623-31. PubMed ID: 12942590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
